Form 8-K - Current report:
SEC Accession No. 0000950170-24-117934
Filing Date
2024-10-29
Accepted
2024-10-29 07:17:03
Documents
16
Period of Report
2024-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ivvd-20241029.htm   iXBRL 8-K 51430
2 EX-99.1 ivvd-ex99_1.htm EX-99.1 37719
3 EX-99.2 ivvd-ex99_2.htm EX-99.2 45248
4 GRAPHIC img59752938_0.jpg GRAPHIC 11948
5 GRAPHIC img60676459_0.jpg GRAPHIC 11948
6 GRAPHIC img60676459_1.jpg GRAPHIC 34323
  Complete submission text file 0000950170-24-117934.txt   362190

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20241029.xsd EX-101.SCH 32063
18 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20241029_htm.xml XML 4874
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 241402678
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)